Myeloma and Amyloidosis Disorder Program
The Myeloma and Amyloidosis Disorder Program team is committed to developing and expanding research efforts through collaboration in an effort to find treatments for myeloma.
Our physician investigators engage in innovative research to develop and implement novel and effective treatments for myeloma. Our team includes clinical and research faculty, physician faculty who are experts in bone marrow transplants and collaborators in research, teaching and patient care. Visit KU Cancer Center for more information about myeloma diagnosis and treatment.
About Our Team
Clinical and Research Faculty
Sid Ganguly, M.D.
Professor of Medicine
Deputy Director, Hematologic Malignancies and Cellular Therapeutics
Al-Ola Abdallah, M.D.
Assistant Professor of Medicine
Leyla Shune, M.D.
Assistant Professor of Medicine
Physician Faculty
Sunil Abhyankar, M.D.
Professor of Medicine
Medical Director, Pheresis and Cell Processing
Tara Lin, M.D.
Associate Professor of Medicine
Joseph McGuirk, D.O.
Schutte-Speas Professor of Hematology-Oncology
Division Director, Division of Hematologic Malignancies and Cellular Therapeutics
Medical Director, Blood and Marrow Transplant Program
Anurag Singh, M.D.
Associate Professor of Medicine
Collaborating Research Scientist
Andy Godwin, Ph.D.
Chancellors Distinguished Chair in Biomedical Sciences and Endowed Professor
Professor and Director of Molecular Oncology, Pathology & Laboratory Medicine
Associated Faculty
- Ahmad Tuffaha, M.D.- Nephrology
- Dawood Sayed, M.D.- Anesthesiology
- Charles Porter, M.D.- Cardiovascular Medicine
- Meagan Dwyer, Ph.D.- Oncology Psychology
- Jessica Hamilton, Ph.D.- Oncology Psychology
- Elizabeth Muenks,Ph.D.- Oncology Psychology
- Karin Porter-Williamson, M.D.- Palliative Care
- Christian Sinclair, M.D.- Palliative Care
- Megan Clark, M.D.- Oncology Rehabilitation
- Mazen M Dimachkie, M.D.- Neurology
- Mamatha Pasnoor, M.D.- Neurology
Clinical Trials
Explore all of our clinical studies underway at The University of Kansas Cancer Center, or reach out for more information.
Contact our Clinical Trial Nurse Navigator:
Phone: 913-945-7552
Email: CTNurseNav@kumc.edu
Featured Clinical Trials:
- Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- PI: Al-Ola Abdallah, MD
- NCT# 03194867- Visit clinicaltrials.gov to learn national information about this trial.
- Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT)
- PI: Al-Ola Abdallah, MD
- NCT# 03289299- Visit clinicaltrials.gov to learn national information about this trial.
- An Exploratory Trial to Estimate the Proportion of Patients With Tumor Cell Contaminated, Flow Positive Leukapheresis Products Collected With and Without Bortezomib as In-vivo Purging Prior to Autologous Stem Cell Harvest for Multiple Myeloma
- PI: Siddhartha Ganguly, MD
- NCT# 02703779- Visit clinicaltrials.gov to learn national information about this trial.
All Myeloma Clinical Trials:
Support Programs
Visit KU Cancer Center for information about support groups and other resources for patients and families. Visit Gilda's Club (support for all cancers and stages) or Cancer Action (for programs and services of persons with cancer, their family and friends).